Impact of fatty acids on brain circulation, structure and function

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 92, Issue , 2015, Pages 3-14

  Haast, Roy A M ^a   Kiliaan, Amanda J ^a  

^a RADBOUD UNIVERSITY   (Netherlands)

Author keywords

Cerebral circulation; Cerebral structure and cerebral function; High fat diet; Mediterranean diet; Omega 3 long chain polyunsaturated fatty acids

Indexed keywords

ACETYLCHOLINE; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN PROTEIN; CHOLINE; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LONG CHAIN FATTY ACID; NEUROPROTECTIN D1; NITRIC OXIDE SYNTHASE; OMEGA 3 FATTY ACID; SATURATED FATTY ACID; SCOPOLAMINE; UNCLASSIFIED DRUG; FATTY ACID;

ACETYLCHOLINE BRAIN LEVEL; AGING; ALZHEIMER DISEASE; AUTOREGULATION; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN CIRCULATION; BRAIN DEVELOPMENT; BRAIN DISEASE; BRAIN FUNCTION; BRAIN PERFUSION; CELL MEMBRANE FLUIDITY; COGNITION; CORPUS CALLOSUM; DEMENTIA; DIET SUPPLEMENTATION; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; FAT INTAKE; FATTY ACID BLOOD LEVEL; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; IMMUNOMODULATION; MILD COGNITIVE IMPAIRMENT; MYELINATION; NERVE CELL MEMBRANE; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVOUS SYSTEM PARAMETERS; NEUROANATOMY; NEUROIMAGING; NEUROPROTECTION; NEUROVASCULAR COUPLING; NONHUMAN; OBESITY; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; REVIEW; SOMATOSENSORY CORTEX; WHITE MATTER; ANIMAL; BRAIN; LIPID METABOLISM; MEDITERRANEAN DIET; METABOLIC SYNDROME X; METABOLISM; PATHOLOGY; PHYSIOLOGY; VASCULARIZATION;

ANIMALIA;

ANIMALS; BRAIN; CEREBROVASCULAR CIRCULATION; DIET, MEDITERRANEAN; FATTY ACIDS; HUMANS; LIPID METABOLISM; METABOLIC SYNDROME X; OBESITY;

EID: 84921437772     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2014.01.002     Document Type: Review

References (147)

1. Cunnane S.C., Crawford M.A. Survival of the fattest: fat babies were the key to evolution of the large human brain. Comp. Biochem. Physiol. Part A, Mol. Integr. Physiol. 2003, 136:17-26.
2. Thompson M.E., Wrangham R.W. Diet and reproductive function in wild female chimpanzees (Pan troglodytes schweinfurthii) at Kibale National Park, Uganda. Am. J. Phys. Anthropol. 2008, 135:171-181.
3. Gibbons A. Paleoanthropology. Food for thought. Science 2007, 316:1558-1560.
4. Crawford M.A., Bloom M., Broadhurst C.L., Schmidt W.F., Cunnane S.C., Galli C., Gehbremeskel K., Linseisen F., Lloyd-Smith J., Parkington J. Evidence for the unique function of docosahexaenoic acid during the evolution of the modern hominid brain. Lipids 1999, 34(suppl.):S39-S47.
5. Simopoulos A.P. What is so special about the diet of Greece? The scientific evidence. World Rev. Nutr. Diet. 2005, 95:80-92.
6. Cordain L., Eaton S.B., Sebastian A., Mann N., Lindeberg S., Watkins B.A., O'Keefe J.H., Brand-Miller J. Origins and evolution of the Western diet: health implications for the 21st century. Am. J. Clin. Nutr. 2005, 81:341-354.
7. Soule G.H., Allbaugh L.G., Barnard C.I. Crete, a Case Study of an Underdeveloped Area, by Leland G. Allbaugh,... With the Editorial Assistance of George Soule. [Foreword by Chester I. Barnard.], N.J. 1953, Princeton University Press.
8. Lee J.H., O'Keefe J.H., Lavie C.J., Marchioli R., Harris W.S. Omega-3 fatty acids for cardioprotection. Mayo Clin. Proc., Mayo Clinic 2008, 83:324-332.
9. Gomez-Pinilla F. Brain foods: the effects of nutrients on brain function, Nature reviews. Neuroscience 2008, 9:568-578.
10. Kivipelto M., Helkala E.L., Laakso M.P., Hanninen T., Hallikainen M., Alhainen K., Soininen H., Tuomilehto J., Nissinen A. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. Br. Med. J. 2001, 322:1447-1451.
11. Laitinen M.H., Ngandu T., Rovio S., Helkala E.L., Uusitalo U., Viitanen M., Nissinen A., Tuomilehto J., Soininen H., Kivipelto M. Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based study. Dement. Geriatr. Cogn. Disord. 2006, 22:99-107.
12. Peters A., Schweiger U., Pellerin L., Hubold C., Oltmanns K.M., Conrad M., Schultes B., Born J., Fehm H.L. The selfish brain: competition for energy resources. Neurosci. Biobehav. Rev. 2004, 28:143-180.
13. Haast R.A., Gustafson D.R., Kiliaan A.J. Sex differences in stroke. J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab. 2012, 32:2100-2107.
14. de la Torre J.C. Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2002, 33:1152-1162.
15. Sabayan B., Jansen S., Oleksik A.M., van Osch M.J., van Buchem M.A., van Vliet P., de Craen A.J., Westendorp R.G. Cerebrovascular hemodynamics in Alzheimer's disease and vascular dementia: a meta-analysis of transcranial Doppler studies. Ageing Res. Rev. 2012, 11:271-277.
16. Vicenzini E., Ricciardi M.C., Altieri M., Puccinelli F., Bonaffini N., Di Piero V., Lenzi G.L. Cerebrovascular reactivity in degenerative and vascular dementia: a transcranial Doppler study. Eur. Neurol. 2007, 58:84-89.
17. Zerbi V., Jansen D., Dederen P.J., Veltien A., Hamans B., Liu Y., Heerschap A., Kiliaan A.J. Microvascular cerebral blood volume changes in aging APPswe/PS1 dE9 AD mouse model: a voxel-wise approach. Brain Struct. Funct. 2013, 218:1085-1098.
18. V. Zerbi, D. Jansen, M. Wiesmann, X. Fang, L.M. Broersen, A. Veltien, A. Heerschap, A.J. Kiliaan, Multi-nutrient diets improve cerebral perfusion and neuroprotection in an Alzheimer mouse model, Neurobiol. Aging, (2013).
19. d'Uscio L.V., Baker T.A., Mantilla C.B., Smith L., Weiler D., Sieck G.C., Katusic Z.S. Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1017-1022.
20. Kitayama J., Faraci F.M., Lentz S.R., Heistad D.D. Cerebral vascular dysfunction during hypercholesterolemia. Stroke 2007, 38:2136-2141.
21. Li W., Prakash R., Chawla D., Du W., Didion S.P., Filosa J.A., Zhang Q., Brann D.W., Lima V.V., Tostes R.C., Ergul A. Early effects of high-fat diet on neurovascular function and focal ischemic brain injury. Am. J. Physiol. Regul., Integr. Comp. Physiol. 2013, 304:R1001-R1008.
22. Ohara Y., Peterson T.E., Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 1993, 91:2546-2551.
23. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 2004, 5:347-360.
24. Paulson O.B., Strandgaard S., Edvinsson L. Cerebral autoregulation. Cerebrovasc. Brain Metab. Rev. 1990, 2:161-192.
25. Hooijmans C.R., Van der Zee C.E., Dederen P.J., Brouwer K.M., Reijmer Y.D., van Groen T., Broersen L.M., Lutjohann D., Heerschap A., Kiliaan A.J. DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice. Neurobiol. Dis. 2009, 33:482-498.
26. Jackson P.A., Reay J.L., Scholey A.B., Kennedy D.O. Docosahexaenoic acid-rich fish oil modulates the cerebral hemodynamic response to cognitive tasks in healthy young adults. Biol. Psychol. 2012, 89:183-190.
27. Tsukada H., Kakiuchi T., Fukumoto D., Nishiyama S., Koga K. Docosahexaenoic acid (DHA) improves the age-related impairment of the coupling mechanism between neuronal activation and functional cerebral blood flow response: a PET study in conscious monkeys. Brain Res. 2000, 862:180-186.
28. Blondeau N., Petrault O., Manta S., Giordanengo V., Gounon P., Bordet R., Lazdunski M., Heurteaux C. Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel. Circ. Res. 2007, 101:176-184.
29. Nguemeni C., Gouix E., Bourourou M., Heurteaux C., Blondeau N. Alpha-linolenic acid: a promising nutraceutical for the prevention of stroke. PharmaNutrition 2013, 1:1-8.
30. Wurtman R.J., Cansev M., Sakamoto T., Ulus I.H. Use of phosphatide precursors to promote synaptogenesis. Annu. Rev. Nutr. 2009, 29:59-87.
31. Jansen D., Zerbi V., Janssen C.I., van Rooij D., Zinnhardt B., Dederen P.J., Wright A.J., Broersen L.M., Lutjohann D., Heerschap A., Kiliaan A.J. Impact of a multi-nutrient diet on cognition, brain metabolism, hemodynamics, and plasticity in apoE4 carrier and apoE knockout mice. Brain Str. Funct. 2013.
32. Kennedy E.P., Weiss S.B. The function of cytidine coenzymes in the biosynthesis of phospholipides. J. Biol. Chem. 1956, 222:193-214.
33. Karhunen L.J., Lappalainen R.I., Vanninen E.J., Kuikka J.T., Uusitupa M.I. Regional cerebral blood flow during food exposure in obese and normal-weight women. Brain: J. Neurol. 1997, 120(pt. 9):1675-1684.
34. Bray G.A., Popkin B.M. Dietary fat intake does affect obesity!. Am. J. Clin. Nutr. 1998, 68:1157-1173.
35. Willett W.C., Leibel R.L. Dietary fat is not a major determinant of body fat. Am. J. Med. 2002, 113(suppl. 9B):47S-59S.
36. Parra D., Ramel A., Bandarra N., Kiely M., Martinez J.A., Thorsdottir I. A diet rich in long chain omega-3 fatty acids modulates satiety in overweight and obese volunteers during weight loss. Appetite 2008, 51:676-680.
37. Umhau J.C., Zhou W., Carson R.E., Rapoport S.I., Polozova A., Demar J., Hussein N., Bhattacharjee A.K., Ma K., Esposito G., Majchrzak S., Herscovitch P., Eckelman W.C., Kurdziel K.A., Salem N. Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography. J. Lipid Res. 2009, 50:1259-1268.
38. Tsukada H., Kakiuchi T., Ando I., Shizuno H., Nakanishi S., Ouchi Y. Regulation of cerebral blood flow response to somatosensory stimulation through the cholinergic system: a positron emission tomography study in unanesthetized monkeys. Brain Res. 1997, 749:10-17.
39. Minami M., Kimura S., Endo T., Hamaue N., Hirafuji M., Togashi H., Matsumoto M., Yoshioka M., Saito H., Watanabe S., Kobayashi T., Okuyama H. Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats. Pharmacol. Biochem. Behav. 1997, 58:1123-1129.
40. Kanoski S.E., Davidson T.L. Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity. Physiol. Behav. 2011, 103:59-68.
41. Engstrom K., Saldeen A.S., Yang B., Mehta J.L., Saldeen T. Effect of fish oils containing different amounts of EPA, DHA, and antioxidants on plasma and brain fatty acids and brain nitric oxide synthase activity in rats. Ups. J. Med. Sci. 2009, 114:206-213.
42. Li P., Kim S.W., Li X., Datta S., Pond W.G., Wu G. Dietary supplementation with cholesterol and docosahexaenoic acid increases the activity of the arginine-nitric oxide pathway in tissues of young pigs. Nitric Oxide: Biol. Chem./Off. J. Nitric Oxide Soc. 2008, 19:259-265.
43. Wu G., Meininger C.J. Regulation of nitric oxide synthesis by dietary factors. Annu. Rev. Nutr. 2002, 22:61-86.
44. Duchemin S., Boily M., Sadekova N., Girouard H. The complex contribution of NOS interneurons in the physiology of cerebrovascular regulation. Front. Neural Circuits 2012, 6:51.
45. Hashimoto M., Hossain S., Yamasaki H., Yazawa K., Masumura S. Effects of eicosapentaenoic acid and docosahexaenoic acid on plasma membrane fluidity of aortic endothelial cells. Lipids 1999, 34:1297-1304.
46. Horrocks L.A., Farooqui A.A. Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function. Prostaglandins. Leukot. Essent. Fatty Acids 2004, 70:361-372.
47. Kok F.J., Kromhout D. Atherosclerosis-epidemiological studies on the health effects of a Mediterranean diet. Eur. J. Nutr. 2004, 43(suppl. 1):I/2S-I/5S.
48. Marin C., Yubero-Serrano E.M., Lopez-Miranda J., Perez-Jimenez F. Endothelial aging associated with oxidative stress can be modulated by a healthy mediterranean diet. Int. J. Mol. Sci. 2013, 14:8869-8889.
49. Fotuhi M., Mohassel P., Yaffe K. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat. Clin. Pract. Neurol. 2009, 5:140-152.
50. Keogh J.B., Grieger J.A., Noakes M., Clifton P.M. Flow-mediated dilatation is impaired by a high-saturated fat diet but not by a high-carbohydrate diet. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1274-1279.
51. Chen J.J., Rosas H.D., Salat D.H. The relationship between cortical blood flow and sub-cortical white-matter health across the adult age span. PloS One 2013, 8:e56733.
52. Basser P.J., Mattiello J., LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys. J. 1994, 66:259-267.
53. Alexander A.L., Lee J.E., Lazar M., Field A.S. Diffusion tensor imaging of the brain. Neurother.: J. Am. Soc. Exp. NeuroTher. 2007, 4:316-329.
54. Hanyu H., Sakurai H., Iwamoto T., Takasaki M., Shindo H., Abe K. Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease. J. Neurol. Sci. 1998, 156:195-200.
55. Kantarci K., Petersen R.C., Boeve B.F., Knopman D.S., Weigand S.D., O'Brien P.C., Shiung M.M., Smith G.E., Ivnik R.J., Tangalos E.G., Jack C.R. DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 2005, 64:902-904.
56. Zerbi V., Kleinnijenhuis M., Fang X., Jansen D., Veltien A., Van Asten J., Timmer N., Dederen P.J., Kiliaan A.J., Heerschap A. Gray and white matter degeneration revealed by diffusion in an Alzheimer mouse model. Neurobiol. Aging 2013, 34:1440-1450.
57. Chen H., Epelbaum S., Delatour B. Fiber tracts anomalies in APPxPS1 transgenic mice modeling Alzheimer's disease. J. Aging Res. 2011, 2011:281274.
58. Song S.K., Kim J.H., Lin S.J., Brendza R.P., Holtzman D.M. Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition. Neurobiol. Dis. 2004, 15:640-647.
59. Ge Y., Grossman R.I., Babb J.S., Rabin M.L., Mannon L.J., Kolson D.L. Age-related total gray matter and white matter changes in normal adult brain. Part I: volumetric MR imaging analysis. AJNR Am. J. Neuroradiol. 2002, 23:1327-1333.
60. Salat D.H., Tuch D.S., Greve D.N., van der Kouwe A.J., Hevelone N.D., Zaleta A.K., Rosen B.R., Fischl B., Corkin S., Rosas H.D., Dale A.M. Age-related alterations in white matter microstructure measured by diffusion tensor imaging. Neurobiol. Aging 2005, 26:1215-1227.
61. Bhagat Y.A., Beaulieu C. Diffusion anisotropy in subcortical white matter and cortical gray matter: changes with aging and the role of CSF-suppression. J. Magn. Resonance Imaging: JMRI 2004, 20:216-227.
62. Broersen L.M., Kuipers A.A., Balvers M., van Wijk N., Savelkoul P.J., de Wilde M.C., van der Beek E.M., Sijben J.W., Hageman R.J., Kamphuis P.J., Kiliaan A.J. A specific multi-nutrient diet reduces Alzheimer-like pathology in young adult AbetaPPswe/PS1dE9 mice. J. Alzheimer's Disease: JAD 2013, 33:177-190.
63. Scheltens P., Twisk J.W., Blesa R., Scarpini E., von Arnim C.A., Bongers A., Harrison J., Swinkels S.H., Stam C.J., de Waal H., Wurtman R.J., Wieggers R.L., Vellas B., Kamphuis P.J. Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J. Alzheimer's Disease: JAD 2012, 31:225-236.
64. Quinn J.F., Raman R., Thomas R.G., Yurko-Mauro K., Nelson E.B., Van Dyck C., Galvin J.E., Emond J., Jack C.R., Weiner M., Shinto L., Aisen P.S. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA: J. Am. Med. Assoc. 2010, 304:1903-1911.
65. Witte A.V., Kerti L., Hermannstadter H.M., Fiebach J.B., Schreiber S.J., Schuchardt J.P., Hahn A., Floel A. Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb. Cortex 2013.
66. Conklin S.M., Gianaros P.J., Brown S.M., Yao J.K., Hariri A.R., Manuck S.B., Muldoon M.F. Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci. Lett. 2007, 421:209-212.
67. Tan Z.S., Harris W.S., Beiser A.S., Au R., Himali J.J., Debette S., Pikula A., Decarli C., Wolf P.A., Vasan R.S., Robins S.J., Seshadri S. Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology 2012, 78:658-664.
68. Bowman G.L., Silbert L.C., Howieson D., Dodge H.H., Traber M.G., Frei B., Kaye J.A., Shannon J., Quinn J.F. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology 2012, 78:241-249.
69. Bourre J.M. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2: macronutrients. J. Nutr. Health. Aging. 2006, 10:386-399.
70. Akbar M., Calderon F., Wen Z., Kim H.Y. Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:10858-10863.
71. Akbar M., Kim H.Y. Protective effects of docosahexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway. J. Neurochem. 2002, 82:655-665.
72. Bazan N.G. Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr. Opin. Clin. Nutr. Metab. Care. 2007, 10:136-141.
73. Calon F., Lim G.P., Yang F., Morihara T., Teter B., Ubeda O., Rostaing P., Triller A., Salem N., Ashe K.H., Frautschy S.A., Cole G.M. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 2004, 43:633-645.
74. Kane D.J., Sarafian T.A., Anton R., Hahn H., Gralla E.B., Valentine J.S., Ord T., Bredesen D.E. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 1993, 262:1274-1277.
75. Salvati S., Natali F., Attorri L., Di Benedetto R., Leonardi F., Di Biase A., Ferri F., Fortuna S., Lorenzini P., Sanchez M., Ricceri L., Vitelli L. Eicosapentaenoic acid stimulates the expression of myelin proteins in rat brain. J. Neurosci. Res. 2008, 86:776-784.
76. Heurteaux C., Laigle C., Blondeau N., Jarretou G., Lazdunski M. Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia. Neuroscience 2006, 137:241-251.
77. Lauritzen I., Blondeau N., Heurteaux C., Widmann C., Romey G., Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO. J. 2000, 19:1784-1793.
78. Orr S.K., Trepanier M.O., Bazinet R.P. n-3 Polyunsaturated fatty acids in animal models with neuroinflammation. Prostaglandins. Leukot. Essent. Fatty. Acids. 2013, 88:97-103.
79. Belayev L., Khoutorova L., Atkins K.D., Eady T.N., Hong S., Lu Y., Obenaus A., Bazan N.G. Docosahexaenoic Acid therapy of experimental ischemic stroke. Translational stroke research 2011, 2:33-41.
80. SanGiovanni J.P., Parra-Cabrera S., Colditz G.A., Berkey C.S., Dwyer J.T. Meta-analysis of dietary essential fatty acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy preterm infants. Pediatrics 2000, 105:1292-1298.
81. Florent S., Malaplate-Armand C., Youssef I., Kriem B., Koziel V., Escanye M.C., Fifre A., Sponne I., Leininger-Muller B., Olivier J.L., Pillot T., Oster T. Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid-beta oligomers. J. Neurochem. 2006, 96:385-395.
82. Eckert G.P., Lipka U., Muller W.E. Omega-3 fatty acids in neurodegenerative diseases: focus on mitochondria. Prostaglandins. Leukot. Essent. Fatty. Acids. 2013, 88:105-114.
83. Madden D.J., Whiting W.L., Huettel S.A., White L.E., MacFall J.R., Provenzale J.M. Diffusion tensor imaging of adult age differences in cerebral white matter: relation to response time. NeuroImage 2004, 21:1174-1181.
84. O'Sullivan M., Jones D.K., Summers P.E., Morris R.G., Williams S.C., Markus H.S. Evidence for cortical "disconnection" as a mechanism of age-related cognitive decline. Neurology 2001, 57:632-638.
85. Schmidt-Wilcke T., Poljansky S., Hierlmeier S., Hausner J., Ibach B. Memory performance correlates with gray matter density in the ento-/perirhinal cortex and posterior hippocampus in patients with mild cognitive impairment and healthy controls--a voxel based morphometry study. NeuroImage 2009, 47:1914-1920.
86. Tisserand D.J., van Boxtel M.P., Pruessner J.C., Hofman P., Evans A.C., Jolles J. A voxel-based morphometric study to determine individual differences in gray matter density associated with age and cognitive change over time. Cerebral cortex 2004, 14:966-973.
87. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298:789-791.
88. McCann J.C., Ames B.N. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am. J. Clin. Nutr. 2005, 82:281-295.
89. Fontani G., Corradeschi F., Felici A., Alfatti F., Migliorini S., Lodi L. Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur. J. Clin. Invest. 2005, 35:691-699.
90. van Gelder B.M., Tijhuis M., Kalmijn S., Kromhout D. Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study. Am. J. Clin. Nutr. 2007, 85:1142-1147.
91. Francis H., Stevenson R. The longer-term impacts of Western diet on human cognition and the brain. Appetite 2013, 63:119-128.
92. Agostoni C., Trojan S., Bellu R., Riva E., Giovannini M. Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice: the role of long-chain polyunsaturated fatty acids. Pediatr. Res. 1995, 38:262-266.
93. Birch E.E., Garfield S., Hoffman D.R., Uauy R., Birch D.G. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev. Med. Child. Neurol. 2000, 42:174-181.
94. Helland I.B., Smith L., Saarem K., Saugstad O.D., Drevon C.A. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003, 111:e39-e44.
95. Hoffman D.R., Birch E.E., Birch D.G., Uauy R., Castaneda Y.S., Lapus M.G., Wheaton D.H. Impact of early dietary intake and blood lipid composition of long-chain polyunsaturated fatty acids on later visual development. J. Pediatr. Gastroenterol. Nutr. 2000, 31:540-553.
96. Kidd P.M. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Alternative medicine review: a journal of clinical therapeutic 2007, 12:207-227.
97. McNamara R.K., Able J., Jandacek R., Rider T., Tso P., Eliassen J.C., Alfieri D., Weber W., Jarvis K., DelBello M.P., Strakowski S.M., Adler C.M. Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study. Am. J. Clin. Nutr. 2010, 91:1060-1067.
98. Muldoon M.F., Ryan C.M., Sheu L., Yao J.K., Conklin S.M., Manuck S.B. Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthood. J. Nutr. 2010, 140:848-853.
99. Narendran R., Frankle W.G., Mason N.S., Muldoon M.F., Moghaddam B. Improved working memory but no effect on striatal vesicular monoamine transporter type 2 after omega-3 polyunsaturated fatty acid supplementation. PloS one 2012, 7:e46832.
100. Aberg M.A., Aberg N., Brisman J., Sundberg R., Winkvist A., Toren K. Fish intake of Swedish male adolescents is a predictor of cognitive performance. Acta. Paediatr. 2009, 98:555-560.
101. Dullemeijer C., Durga J., Brouwer I.A., van de Rest O., Kok F.J., Brummer R.J., van Boxtel M.P., Verhoef P. n 3 fatty acid proportions in plasma and cognitive performance in older adults. Am. J. Clin. Nutr. 2007, 86:1479-1485.
102. Yurko-Mauro K., McCarthy D., Rom D., Nelson E.B., Ryan A.S., Blackwell A., Salem N., Stedman M., Investigators M. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimer's & dementia: the journal of the Alzheimer's Association 2010, 6:456-464.
103. Scarmeas N., Stern Y., Tang M.X., Mayeux R., Luchsinger J.A. Mediterranean diet and risk for Alzheimer's disease. Ann. Neurol. 2006, 59:912-921.
104. Barberger-Gateau P., Raffaitin C., Letenneur L., Berr C., Tzourio C., Dartigues J.F., Alperovitch A. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 2007, 69:1921-1930.
105. Scheltens P., Kamphuis P.J., Verhey F.R., Olde Rikkert M.G., Wurtman R.J., Wilkinson D., Twisk J.W., Kurz A. Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial. Alzheimer's & dementia: the journal of the Alzheimer's Association. 1-10 e11 2010, 6.
106. Freund-Levi Y., Eriksdotter-Jonhagen M., Cederholm T., Basun H., Faxen-Irving G., Garlind A., Vedin I., Vessby B., Wahlund L.O., Palmblad J. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Archives of neurology 2006, 63:1402-1408.
107. Cunnane S.C., Chouinard-Watkins R., Castellano C.A., Barberger-Gateau P. Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: Can we reconcile the evidence?. Prostaglandins, leukotrienes, and essential fatty acids 2013, 88:61-70.
108. Wiesmann M., Jansen D., Zerbi V., Broersen L.M., Garthe A., Kiliaan A.J. Improved Spatial Learning Strategy and Memory in Aged Alzheimer AbetaPPswe/PS1dE9 Mice on a Multi-Nutrient Diet. Journal of Alzheimer's disease: JAD 2013, 37:233-245.
109. Hooijmans C.R., Pasker-de Jong P.C., de Vries R.B., Ritskes-Hoitinga M. The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis. Journal of Alzheimer's disease: JAD 2012, 28:191-209.
110. van de Rest O., Geleijnse J.M., Kok F.J., van Staveren W.A., Dullemeijer C., Olderikkert M.G., Beekman A.T., de Groot C.P. Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology 2008, 71:430-438.
111. Auestad N., Halter R., Hall R.T., Blatter M., Bogle M.L., Burks W., Erickson J.R., Fitzgerald K.M., Dobson V., Innis S.M., Singer L.T., Montalto M.B., Jacobs J.R., Qiu W., Bornstein M.H. Growth and development in term infants fed long-chain polyunsaturated fatty acids: a double-masked, randomized, parallel, prospective, multivariate study. Pediatrics 2001, 108:372-381.
112. Makrides M., Neumann M.A., Simmer K., Gibson R.A. A critical appraisal of the role of dietary long-chain polyunsaturated fatty acids on neural indices of term infants: a randomized, controlled trial. Pediatrics 2000, 105:32-38.
113. Wainwright P.E., Xing H.C., Ward G.R., Huang Y.S., Bobik E., Auestad N., Montalto M. Water maze performance is unaffected in artificially reared rats fed diets supplemented with arachidonic acid and docosahexaenoic acid. The Journal of nutrition 1999, 129:1079-1089.
114. Okereke O.I., Rosner B.A., Kim D.H., Kang J.H., Cook N.R., Manson J.E., Buring J.E., Willett W.C., Grodstein F. Dietary fat types and 4-year cognitive change in community-dwelling older women. Annals of neurology 2012, 72:124-134.
115. Yaffe K. Treatment of Alzheimer disease and prognosis of dementia: time to translate research to results. JAMA: the journal of the American Medical Association 2010, 304:1952-1953.
116. Kalmijn S., van Boxtel M.P., Ocke M., Verschuren W.M., Kromhout D., Launer L.J. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 2004, 62:275-280.
117. Morris M.C., Evans D.A., Tangney C.C., Bienias J.L., Schneider J.A., Wilson R.S., Scherr P.A. Dietary copper and high saturated and trans fat intakes associated with cognitive decline. Archives of neurology 2006, 63:1085-1088.
118. Edwards L.M., Murray A.J., Holloway C.J., Carter E.E., Kemp G.J., Codreanu I., Brooker H., Tyler D.J., Robbins P.A., Clarke K. Short-term consumption of a high-fat diet impairs whole-body efficiency and cognitive function in sedentary men. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 2011, 25:1088-1096.
119. Holloway C.J., Cochlin L.E., Emmanuel Y., Murray A., Codreanu I., Edwards L.M., Szmigielski C., Tyler D.J., Knight N.S., Saxby B.K., Lambert B., Thompson C., Neubauer S., Clarke K. A high-fat diet impairs cardiac high-energy phosphate metabolism and cognitive function in healthy human subjects. The American journal of clinical nutrition 2011, 93:748-755.
120. Kaplan R.J., Greenwood C.E., Winocur G., Wolever T.M. Dietary protein, carbohydrate, and fat enhance memory performance in the healthy elderly. The American journal of clinical nutrition 2001, 74:687-693.
121. Molteni R., Barnard R.J., Ying Z., Roberts C.K., Gomez-Pinilla F. A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience 2002, 112:803-814.
122. Eskelinen M.H., Ngandu T., Helkala E.L., Tuomilehto J., Nissinen A., Soininen H., Kivipelto M. Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study. International journal of geriatric psychiatry 2008, 23:741-747.
123. Kalmijn S., Launer L.J., Ott A., Witteman J.C., Hofman A., Breteler M.M. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Annals of neurology 1997, 42:776-782.
124. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Bennett D.A., Aggarwal N., Schneider J., Wilson R.S. Dietary fats and the risk of incident Alzheimer disease. Archives of neurology 2003, 60:194-200.
125. Bayer-Carter J.L., Green P.S., Montine T.J., VanFossen B., Baker L.D., Watson G.S., Bonner L.M., Callaghan M., Leverenz J.B., Walter B.K., Tsai E., Plymate S.R., Postupna N., Wilkinson C.W., Zhang J., Lampe J., Kahn S.E., Craft S. Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment. Archives of neurology 2011, 68:743-752.
126. Refolo L.M., Malester B., LaFrancois J., Bryant-Thomas T., Wang R., Tint G.S., Sambamurti K., Duff K., Pappolla M.A. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiology of disease 2000, 7:321-331.
127. Shie F.S., Jin L.W., Cook D.G., Leverenz J.B., LeBoeuf R.C. Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice. Neuroreport 2002, 13:455-459.
128. Cao D., Lu H., Lewis T.L., Li L. Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. The Journal of biological chemistry 2007, 282:36275-36282.
129. Cao D., Kevala K., Kim J., Moon H.S., Jun S.B., Lovinger D., Kim H.Y. Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. Journal of neurochemistry 2009, 111:510-521.
130. Cansev M., Wurtman R.J. Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils. Neuroscience 2007, 148:421-431.
131. McGahon B.M., Martin D.S., Horrobin D.F., Lynch M.A. Age-related changes in synaptic function: analysis of the effect of dietary supplementation with omega-3 fatty acids. Neuroscience 1999, 94:305-314.
132. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
133. Kavraal S., Oncu S.K., Bitiktas S., Artis A.S., Dolu N., Gunes T., Suer C. Maternal intake of Omega-3 essential fatty acids improves long term potentiation in the dentate gyrus and Morris water maze performance in rats. Brain research 2012, 1482:32-39.
134. Cao D., Xue R., Xu J., Liu Z. Effects of docosahexaenoic acid on the survival and neurite outgrowth of rat cortical neurons in primary cultures. The Journal of nutritional biochemistry 2005, 16:538-546.
135. Robson L.G., Dyall S., Sidloff D., Michael-Titus A.T. Omega-3 polyunsaturated fatty acids increase the neurite outgrowth of rat sensory neurones throughout development and in aged animals. Neurobiology of aging 2010, 31:678-687.
136. Wu A., Ying Z., Gomez-Pinilla F. Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience 2008, 155:751-759.
137. Wu A., Ying Z., Gomez-Pinilla F. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. Journal of neurotrauma 2004, 21:1457-1467.
138. Pifferi F., Jouin M., Alessandri J.M., Haedke U., Roux F., Perriere N., Denis I., Lavialle M., Guesnet P. n-3 Fatty acids modulate brain glucose transport in endothelial cells of the blood-brain barrier. Prostaglandins, leukotrienes, and essential fatty acids 2007, 77:279-286.
139. Peng S., Wuu J., Mufson E.J., Fahnestock M. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. Journal of neurochemistry 2005, 93:1412-1421.
140. Connor B., Young D., Yan Q., Faull R.L., Synek B., Dragunow M. Brain-derived neurotrophic factor is reduced in Alzheimer's disease, Brain research. Molecular brain research 1997, 49:71-81.
141. Kanoski S.E., Meisel R.L., Mullins A.J., Davidson T.L. The effects of energy-rich diets on discrimination reversal learning and on BDNF in the hippocampus and prefrontal cortex of the rat. Behavioral brain research 2007, 182:57-66.
142. Wu A., Ying Z., Gomez-Pinilla F. The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition. The European journal of neuroscience 2004, 19:1699-1707.
143. Arnsten A.F., Li B.M. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biological psychiatry 2005, 57:1377-1384.
144. Morris R.G., Garrud P., Rawlins J.N., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982, 297:681-683.
145. Winocur G., Greenwood C.E. Studies of the effects of high fat diets on cognitive function in a rat model. Neurobiology of aging 2005, 26(Suppl 1):46-49.
146. Meireles M., Martel F., Araujo J., Santos-Buelga C., Gonzalez-Manzano S., Duenas M., de Freitas V., Mateus N., Calhau C., Faria A. Characterization and modulation of glucose uptake in a human blood-brain barrier model. The Journal of membrane biology 2013, 246:669-677.
147. Freeman L.R., Granholm A.C. Vascular changes in rat hippocampus following a high saturated fat and cholesterol diet. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 2012, 32:643-653.